Memorial Hospital Los Banos | |
520 West I St, Los Banos, California 93635 | |
(209) 826-0591 | |
Name | Memorial Hospital Los Banos |
---|---|
Type | Acute Care Hospital |
Location | 520 West I St, Los Banos, California |
Ownership | Voluntary non-profit - Private |
Emergency Services | Yes |
Medicare ID (CCN) | 050528 |
NPI Number | 1033352125 |
Organization Name | SUTTER CENTRAL VALLEY HOSPITALS |
Doing Business As | MEMORIAL HOSPITAL LOS BANOS |
Address | 520 W I Street, Los Banos, CA 93635 |
Hospital Type | General Acute Care Hospital |
Phone Number | 209-826-0591 |
News Archive
Nabi Biopharmaceuticals today announced its first quarter financial results for the three month period ended March 27, 2010. The Company reported net income from continuing operations of $5.5 million, or $0.11 per share, compared to a net loss of $7.0 million, or $0.14 per share, for the period ended March 28, 2009.
In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P. Velarde) pp. 375-389(15); DOI: https://doi.org/10.15212/CVIA.2019.0007 Viviany R. Taqueti from the Cardiovascular Imaging Program, Heart and Vascular Center, Division of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA reviews novel imaging approaches for the diagnosis of stable ischemic heart disease in women.
Roll Call: "Industry groups, labor unions and other stakeholders in health care reform offered up their parting shots on Monday, airing lingering grievances with the historic legislation or praising a bill that, after more than a year of tussling, now awaits President Barack Obama's signature.
Sirion Therapeutics has announced that it has initiated new phase III clinical programs for two of its pipeline compounds, ST-601 (difluprednate) and ST-603 (cyclosporine).
› Verified 9 days ago
NPI Number | 1144866468 |
Organization Name | TRUEHEALTHCARE |
Address | 520 W I St, Los Banos, CA 93635 |
Hospital Type | General Acute Care Hospital |
Phone Number | 209-826-0591 |
News Archive
Nabi Biopharmaceuticals today announced its first quarter financial results for the three month period ended March 27, 2010. The Company reported net income from continuing operations of $5.5 million, or $0.11 per share, compared to a net loss of $7.0 million, or $0.14 per share, for the period ended March 28, 2009.
In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P. Velarde) pp. 375-389(15); DOI: https://doi.org/10.15212/CVIA.2019.0007 Viviany R. Taqueti from the Cardiovascular Imaging Program, Heart and Vascular Center, Division of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA reviews novel imaging approaches for the diagnosis of stable ischemic heart disease in women.
Roll Call: "Industry groups, labor unions and other stakeholders in health care reform offered up their parting shots on Monday, airing lingering grievances with the historic legislation or praising a bill that, after more than a year of tussling, now awaits President Barack Obama's signature.
Sirion Therapeutics has announced that it has initiated new phase III clinical programs for two of its pipeline compounds, ST-601 (difluprednate) and ST-603 (cyclosporine).
› Verified 9 days ago
NPI Number | 1154302271 |
Organization Name | MEMORAIL HOSPITAL OF LOS BANOS |
Address | 520 I Street, Los Banos, CA 93635 |
Hospital Type | General Acute Care Hospital |
Phone Number | 209-826-0591 |
News Archive
Nabi Biopharmaceuticals today announced its first quarter financial results for the three month period ended March 27, 2010. The Company reported net income from continuing operations of $5.5 million, or $0.11 per share, compared to a net loss of $7.0 million, or $0.14 per share, for the period ended March 28, 2009.
In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P. Velarde) pp. 375-389(15); DOI: https://doi.org/10.15212/CVIA.2019.0007 Viviany R. Taqueti from the Cardiovascular Imaging Program, Heart and Vascular Center, Division of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA reviews novel imaging approaches for the diagnosis of stable ischemic heart disease in women.
Roll Call: "Industry groups, labor unions and other stakeholders in health care reform offered up their parting shots on Monday, airing lingering grievances with the historic legislation or praising a bill that, after more than a year of tussling, now awaits President Barack Obama's signature.
Sirion Therapeutics has announced that it has initiated new phase III clinical programs for two of its pipeline compounds, ST-601 (difluprednate) and ST-603 (cyclosporine).
› Verified 9 days ago
NPI Number | 1366896300 |
Organization Name | SUTTER VALLEY HOSPITALS |
Doing Business As | MEMORIAL HOSPITAL LOS BANOS |
Address | 520 W I St, Los Banos, CA 93635 |
Hospital Type | General Acute Care Hospital |
Phone Number | 209-826-0591 |
News Archive
Nabi Biopharmaceuticals today announced its first quarter financial results for the three month period ended March 27, 2010. The Company reported net income from continuing operations of $5.5 million, or $0.11 per share, compared to a net loss of $7.0 million, or $0.14 per share, for the period ended March 28, 2009.
In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P. Velarde) pp. 375-389(15); DOI: https://doi.org/10.15212/CVIA.2019.0007 Viviany R. Taqueti from the Cardiovascular Imaging Program, Heart and Vascular Center, Division of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA reviews novel imaging approaches for the diagnosis of stable ischemic heart disease in women.
Roll Call: "Industry groups, labor unions and other stakeholders in health care reform offered up their parting shots on Monday, airing lingering grievances with the historic legislation or praising a bill that, after more than a year of tussling, now awaits President Barack Obama's signature.
Sirion Therapeutics has announced that it has initiated new phase III clinical programs for two of its pipeline compounds, ST-601 (difluprednate) and ST-603 (cyclosporine).
› Verified 9 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Nabi Biopharmaceuticals today announced its first quarter financial results for the three month period ended March 27, 2010. The Company reported net income from continuing operations of $5.5 million, or $0.11 per share, compared to a net loss of $7.0 million, or $0.14 per share, for the period ended March 28, 2009.
In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P. Velarde) pp. 375-389(15); DOI: https://doi.org/10.15212/CVIA.2019.0007 Viviany R. Taqueti from the Cardiovascular Imaging Program, Heart and Vascular Center, Division of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA reviews novel imaging approaches for the diagnosis of stable ischemic heart disease in women.
Roll Call: "Industry groups, labor unions and other stakeholders in health care reform offered up their parting shots on Monday, airing lingering grievances with the historic legislation or praising a bill that, after more than a year of tussling, now awaits President Barack Obama's signature.
Sirion Therapeutics has announced that it has initiated new phase III clinical programs for two of its pipeline compounds, ST-601 (difluprednate) and ST-603 (cyclosporine).
› Verified 9 days ago
Memorial Hospital Los Banos Acute Care Hospital Location: 520 West I St, Los Banos, California 93635 Phone: (209) 826-0591 |